The results were significant: At 48 weeks, participants receiving the 12 mg dose achieved a mean weight reduction of 24.2% (approximately 58 pounds or 26.2 kg) 100% of participants on the 8 mg or 12 mg doses lost at least 5% of their body weight More than 90% of participants on the 12 mg dose lost at least 10% of their body weight Nearly half of participants on the highest dose lost 25% or more of their body weight The study also showed improvements in cardiometabolic markers including blood pressure, triglycerides, LDL cholesterol, and fasting glucose
Continued advancement of the understanding of HIC separation mechanism and increased availability of commercial columns will lead to wider applications of HIC, for example on lysinelinked ADCs, which have yet to be explored
The research chemical market also presents quality concerns
Handling and Storage Recommendations Store unopened vials at 28 C, with 20 C recommended for long-term storage Protect from light and moisture After reconstitution, store solutions at 28 C and use within laboratory-defined timeframes Avoid repeated freeze-thaw cycles Follow standard laboratory safety, labeling, and handling procedures All handling is performed within laboratory research environments
The standardized dosing protocol helps maintain consistent results, while regular monitoring ensures patient safety throughout the treatment journey